IMPG1
Basic information
Region (hg38): 6:75921114-76072678
Previous symbols: [ "SPACR" ]
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa (Moderate), mode of inheritance: AR
- retinitis pigmentosa (Moderate), mode of inheritance: AD
- adult-onset foveomacular vitelliform dystrophy (Supportive), mode of inheritance: AD
- vitelliform macular dystrophy 4 (Moderate), mode of inheritance: AD
- vitelliform macular dystrophy 4 (Definitive), mode of inheritance: AD
- vitelliform macular dystrophy 4 (Strong), mode of inheritance: AD
- inherited retinal dystrophy (Definitive), mode of inheritance: AD
- vitelliform macular dystrophy 4 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Macular dystrophy, vitelliform, 4; Retinitis pigmentosa 91; Retinitis pigmentosa 56 | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 23993198; 25085631; 30589393; 32817297 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (37 variants)
- Vitelliform macular dystrophy 4 (1 variants)
- Vitelliform macular dystrophy 2 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IMPG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 106 | 119 | ||||
missense | 310 | 15 | 332 | |||
nonsense | 13 | 21 | ||||
start loss | 2 | |||||
frameshift | 22 | 24 | ||||
inframe indel | 4 | |||||
splice donor/acceptor (+/-2bp) | 11 | 17 | ||||
splice region | 18 | 24 | 2 | 44 | ||
non coding | 52 | 55 | ||||
Total | 38 | 17 | 332 | 164 | 23 |
Highest pathogenic variant AF is 0.0000460
Variants in IMPG1
This is a list of pathogenic ClinVar variants found in the IMPG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-75922092-A-G | Retinal dystrophy | Conflicting classifications of pathogenicity (Oct 22, 2023) | ||
6-75922100-C-T | Uncertain significance (Mar 10, 2022) | |||
6-75922106-C-T | Retinal dystrophy | Benign (Jan 30, 2024) | ||
6-75922107-T-C | Likely benign (Oct 10, 2023) | |||
6-75922119-T-A | Uncertain significance (Dec 19, 2023) | |||
6-75922121-C-A | Vitelliform macular dystrophy 4 | Uncertain significance (Jan 11, 2023) | ||
6-75922133-C-T | not specified | Conflicting classifications of pathogenicity (Jan 25, 2024) | ||
6-75922139-G-A | Likely benign (Apr 19, 2023) | |||
6-75922144-TC-T | Uncertain significance (Sep 15, 2022) | |||
6-75922158-A-G | Likely benign (Sep 04, 2020) | |||
6-75922159-C-T | not specified | Uncertain significance (Feb 24, 2022) | ||
6-75922166-C-T | Uncertain significance (Oct 22, 2023) | |||
6-75922168-TGAAAGA-T | Uncertain significance (Apr 02, 2022) | |||
6-75922180-A-C | Likely benign (Jun 04, 2022) | |||
6-75923626-G-T | Likely benign (Dec 11, 2022) | |||
6-75923627-A-AT | Benign (Jan 15, 2024) | |||
6-75923634-C-T | Uncertain significance (Jul 02, 2022) | |||
6-75923645-G-A | Uncertain significance (Oct 04, 2022) | |||
6-75923647-T-TGATTTTGGAACTTTTTTTTTTTTTTTTTTTTTTTTTNNNNNNNNNNCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCGCCCCCCCCCCCCGGGAGCGGGAGAGGGAGAGG | Uncertain significance (May 24, 2023) | |||
6-75923656-A-G | Uncertain significance (Nov 03, 2023) | |||
6-75923657-A-C | not specified | Uncertain significance (Mar 01, 2023) | ||
6-75923658-C-A | Uncertain significance (Jul 25, 2022) | |||
6-75923667-A-G | Likely benign (Feb 08, 2022) | |||
6-75923668-C-T | Retinal dystrophy | Benign (Jan 31, 2024) | ||
6-75923705-A-G | Likely benign (Jul 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IMPG1 | protein_coding | protein_coding | ENST00000369950 | 17 | 151564 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.37e-29 | 0.0000339 | 125670 | 0 | 78 | 125748 | 0.000310 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.937 | 476 | 422 | 1.13 | 0.0000211 | 5242 |
Missense in Polyphen | 106 | 97.698 | 1.085 | 1337 | ||
Synonymous | 0.0878 | 154 | 155 | 0.991 | 0.00000863 | 1509 |
Loss of Function | -0.295 | 43 | 41.0 | 1.05 | 0.00000225 | 471 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000754 | 0.000631 |
Ashkenazi Jewish | 0.0000997 | 0.0000992 |
East Asian | 0.000435 | 0.000435 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000356 | 0.000352 |
Middle Eastern | 0.000435 | 0.000435 |
South Asian | 0.000439 | 0.000425 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May interact with hyaluronan which may serve to form a basic macromolecular scaffold comprising the insoluble interphotoreceptor matrix. {ECO:0000269|PubMed:9813076}.;
- Disease
- DISEASE: Macular dystrophy, vitelliform, 4 (VMD4) [MIM:616151]: A form of macular dystrophy, a retinal disease in which various forms of deposits, pigmentary changes, and atrophic lesions are observed in the macula lutea. Vitelliform macular dystrophies are characterized by yellow, lipofuscin-containing deposits, usually localized at the center of the macula. VMD4 features include late- onset moderate visual impairment, small satellite drusen-like lesions in the foveal area, and preservation of retinal pigment epithelium reflectivity. {ECO:0000269|PubMed:23993198}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0918
Intolerance Scores
- loftool
- 0.964
- rvis_EVS
- 0.69
- rvis_percentile_EVS
- 85.29
Haploinsufficiency Scores
- pHI
- 0.269
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0100
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Impg1
- Phenotype
Gene ontology
- Biological process
- visual perception
- Cellular component
- extracellular matrix
- Molecular function
- extracellular matrix structural constituent